Basecamp Wealth Advisors’s Transmedics TMDX Stock Holding History

Basecamp Wealth Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9	Closed	-$1.09K	–	2162
2025 Q4	$1.09K	Buy	+9	New	+$1.13K	﹤0.01%	1475

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Basecamp Wealth Advisors's TMDX Position: Q1 2026 in Review

Basecamp Wealth Advisors sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 9 shares — an estimated $1.09K sold.

Basecamp Wealth Advisors first reported a position in TMDX in Q4 2025 and held it in 1 quarter. The position peaked at $1.09K in Q4 2025. 416 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Basecamp Wealth Advisors reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Basecamp Wealth Advisors sold 9 Transmedics shares in Q1 2026, an estimated $1.09K.
Basecamp Wealth Advisors first reported a position in Transmedics in Q4 2025 and held it in 1 quarter.
Basecamp Wealth Advisors's Transmedics position peaked at $1.09K in Q4 2025.
416 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.